Penumbra, Inc.

Informe acción NYSE:PEN

Capitalización de mercado: US$6.9b

Salud financiera de hoja de balance de Penumbra

Salud financiera controles de criterios 6/6

Penumbra tiene un patrimonio de accionistas total de $1.2B y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $1.6B y $376.3M respectivamente. El BAIT de Penumbra es de $95.9M, por lo que su ratio de cobertura de intereses es de -12.9. Tiene efectivo e inversiones a corto plazo que ascienden a $313.5M.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de intereses-12.9x
EfectivoUS$313.47m
PatrimonioUS$1.20b
Total pasivoUS$376.31m
Activos totalesUS$1.58b

Actualizaciones recientes sobre salud financiera

Recent updates

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Jun 19
Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Penumbra: Appeal Improves As Operating Leverage Continues

May 30

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Apr 12
Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Mar 21
Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Jan 23
Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Nov 16
A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Penumbra: Appeal Improves, Just Not Appealing Yet

Oct 16

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Oct 05
Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

Sep 01

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Aug 15
A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Jun 28
Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Jun 22

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Jun 02
Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Apr 01
We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M

Feb 23

Penumbra Riding Higher On Upcoming Launches And Rerating

Jan 12

Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy

Nov 03

Penumbra cut to Neutral at Citi on macro concerns

Oct 05

Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan

Sep 22

Penumbra stock rises ~11% after announcing European launch of catheters for stroke care

Sep 07

Sector Rerating Has Cast A Shadow Over Penumbra

Aug 18

Penumbra gains as RBC initiates at Outperform with 59% upside

Jul 18

Penumbra: Multiple Downside Targets, Rescued By Long-Term Value Proposition

Jun 10

Penumbra A Little Beaten Down Despite Strong Growth Opportunities

Mar 01

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($935.0M) de PEN superan a sus pasivos a corto plazo ($152.8M).

Pasivo a largo plazo: Los activos a corto plazo de PEN ($935.0M) superan a sus pasivos a largo plazo ($223.5M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: PEN está libre de deudas.

Reducción de la deuda: PEN no tenía deudas hace 5 años.

Cobertura de la deuda: PEN no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: PEN no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.


Hoja de balance


Descubre empresas con salud financiera